- Home
- RMI vs BTMD Comparison
RMI vs BTMD Comparison
Compare RMI & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RMI | BTMD |
|---|---|---|
| Founded | 2018 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.9M | 80.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RMI | BTMD |
|---|---|---|
| Price | $14.59 | $2.20 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 17.4K | ★ 174.0K |
| Earning Date | 01-01-0001 | 03-11-2026 |
| Dividend Yield | ★ 7.28% | N/A |
| EPS Growth | N/A | ★ 270.48 |
| EPS | N/A | ★ 0.78 |
| Revenue | N/A | ★ $195,645,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.80 |
| P/E Ratio | ★ N/A | $2.84 |
| Revenue Growth | N/A | ★ 1.34 |
| 52 Week Low | $13.05 | $2.18 |
| 52 Week High | $17.37 | $5.93 |
Technical Indicators
Market Signals| Indicator | RMI | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 52.63 | 33.43 |
| Support Level | $14.53 | $2.19 |
| Resistance Level | $14.73 | $2.42 |
| Average True Range (ATR) | 0.12 | 0.13 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 59.99 | 8.24 |
Price Performance
Historical ComparisonAbout RMI RiverNorth Opportunistic Municipal Income Fund Inc.
RiverNorth Opportunistic Municipal Income Fund, Inc. is a diversified, closed-end management investment company. Its investment objective is to seek current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.